BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 36139675)

  • 1. Therapeutic Benefit of Systematic Lymphadenectomy in Node-Negative Uterine-Confined Endometrioid Endometrial Carcinoma: Omission of Adjuvant Therapy.
    Otsuka I
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma.
    Otsuka I; Matsuura T; Mitani T; Otsuka K; Kanamoto Y
    Curr Oncol; 2022 May; 29(5):3728-3737. PubMed ID: 35621688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
    Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
    Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
    Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N
    Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
    Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
    Emons G; Kim JW; Weide K; de Gregorio N; Wimberger P; Trillsch F; Gabriel B; Denschlag D; Kommoss S; Aydogdu M; Papathemelis T; Gropp-Meier M; Muallem MZ; Kühn C; Müller A; Frank M; Weigel M; Bronger H; Lampe B; Rau J; Schade-Brittinger C; Harter P
    Int J Gynecol Cancer; 2021 Jul; 31(7):1075-1079. PubMed ID: 34226291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma.
    Mylonas I; Schindlbeck C
    Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic role of para-aortic lymphadenectomy in patients with intermediate- and high-risk endometrial cancer: a systematic review and meta-analysis.
    Pavone M; Jochum F; Lecointre L; Fanfani F; Scambia G; Querleu D; Akladios C
    Int J Gynecol Cancer; 2024 Apr; 34(4):519-527. PubMed ID: 38296516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial).
    Baiocchi G; Andrade CEMC; Ribeiro R; Moretti-Marques R; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Costa RLR; Kumagai LY; Badiglian-Filho L; Faloppa CC; Mantoan H; De Brot L; Dos Reis R; Goncalves BT
    Int J Gynecol Cancer; 2022 May; 32(5):676-679. PubMed ID: 35236752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of a patient with stage IIIC2 grade 3 endometrioid endometrial carcinoma treated with surgery alone.
    Otsuka I; Kadooka M; Matsuura T
    Gynecol Oncol Rep; 2021 Nov; 38():100869. PubMed ID: 34926754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
    Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
    Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenectomy for the management of endometrial cancer.
    Frost JA; Webster KE; Bryant A; Morrison J
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007585. PubMed ID: 26387863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node navigation surgery in cervical and endometrial cancer: a review.
    Niikura H; Tsuji K; Tokunaga H; Shimada M; Ishikawa M; Yaegashi N
    Jpn J Clin Oncol; 2019 Jun; 49(6):495-500. PubMed ID: 31070770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.
    Rathod PS; Shakuntala PN; Pallavi VR; Kundaragi R; Shankaranand B; Vijay CR; Devi KU; Bafna UD
    Indian J Surg Oncol; 2014 Jun; 5(2):109-14. PubMed ID: 25114462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
    Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphadenectomy for the management of endometrial cancer.
    May K; Bryant A; Dickinson HO; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007585. PubMed ID: 20091639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
    Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
    BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.